Showing results (411-420 of 447) with videos related to
Sort By:
Pageof 45
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 31, 2023
Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collectionDustin B Hammers, Ani Eloyan, Alexander Taurone, et al.Brain : a Journal of Neurology|August 4, 2011
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaKatya Rascovsky, John R Hodges, David Knopman, et al.JAMA|June 16, 2025
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography PositivityAlexis Moscoso, Fiona Heeman, Sheelakumari Raghavan, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohortsYuta Katsumi, Alexandra Touroutoglou, Michael Brickhouse, et al.Annals of Clinical and Translational Neurology|September 17, 2025
Functional Connectivity Associations With Markers of Disease Progression in GRN Pathogenic Variant CarriersTaru M Flagan, Stephanie A Chu, Suvi Häkkinen, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 18, 2023
The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) CohortAlexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, et al.Journal of Neurology|April 30, 2026
Factors influencing accelerated progression in behavioral variant frontotemporal dementiaMolly Split, Zachary J Kunicki, Daliah Ross, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 27, 2023
Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's diseaseSára Nemes, Paige E Logan, Mohit K Manchella, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 9, 2023
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohortAngelina J Polsinelli, Ryan J Wonderlin, Dustin B Hammers, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2023
Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease StudyJeffrey L Dage, Ani Eloyan, Maryanne Thangarajah, et al.Pageof 45